These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 33012364)
1. Exclusion of Older Adults in COVID-19 Clinical Trials. Abi Jaoude J; Kouzy R; El Alam MB; Subbiah V; Taniguchi CM; Ludmir EB; Lin TA Mayo Clin Proc; 2020 Oct; 95(10):2293-2294. PubMed ID: 33012364 [No Abstract] [Full Text] [Related]
2. Exclusion of Pregnant Women from Clinical Trials during the Coronavirus Disease 2019 Pandemic: A Review of International Registries. Smith DD; Pippen JL; Adesomo AA; Rood KM; Landon MB; Costantine MM Am J Perinatol; 2020 Jun; 37(8):792-799. PubMed ID: 32428965 [TBL] [Abstract][Full Text] [Related]
5. Include pregnant women in research-particularly covid-19 research. Knight M; Morris RK; Furniss J; Chappell LC BMJ; 2020 Aug; 370():m3305. PubMed ID: 32843352 [No Abstract] [Full Text] [Related]
6. SARS-CoV-2 pandemic and the need for transplant-oriented trials. Zaza G; Benedetti C; Fribourg M; Maggiore U; Azzi J; Riella LV; Cravedi P Transpl Int; 2020 Aug; 33(8):966-968. PubMed ID: 32333712 [No Abstract] [Full Text] [Related]
7. Trials and tribulations of coronavirus disease-2019 research: with a few bright lights in the fog. Di Pasquale G; Maggioni AP; Gervasoni C; Andreotti F J Cardiovasc Med (Hagerstown); 2020 Nov; 21(11):841-844. PubMed ID: 32858645 [No Abstract] [Full Text] [Related]
8. Advantages of Using Lotteries to Select Participants for High-Demand Covid-19 Treatment Trials. Iyer AA; Hendriks S; Rid A Ethics Hum Res; 2020 Jul; 42(4):35-40. PubMed ID: 32567239 [TBL] [Abstract][Full Text] [Related]
9. COVID-19 Trials and Tribulations by Rebecca Gliksman MD MPH. Gliksman R J Occup Environ Med; 2020 Sep; 62(9):e542. PubMed ID: 32890229 [No Abstract] [Full Text] [Related]
10. Ongoing Clinical Trials for the Management of the COVID-19 Pandemic. Lythgoe MP; Middleton P Trends Pharmacol Sci; 2020 Jun; 41(6):363-382. PubMed ID: 32291112 [TBL] [Abstract][Full Text] [Related]
11. Resource Allocation in COVID-19 Research: Which Trials? Which Patients? Wieten S; Burgart A; Cho M Am J Bioeth; 2020 Jul; 20(7):86-88. PubMed ID: 32716767 [No Abstract] [Full Text] [Related]
13. Optimizing COVID-19 Candidate Therapeutics: Thinking Without Borders. Rayner CR; Smith PF; Hershberger K; Wesche D Clin Transl Sci; 2020 Sep; 13(5):830-834. PubMed ID: 32212378 [No Abstract] [Full Text] [Related]
14. COVID-19 impact on multi-site recruitment and enrollment. Strujo E; Sanders M; Fiscella K; Thomas M; Johnson B; Deets A; Sanchez Lucas C; Holder T; Johal N; Luque A; Cassells A; Williams S; Tobin JN Clin Trials; 2020 Oct; 17(5):501-504. PubMed ID: 32815379 [No Abstract] [Full Text] [Related]
15. Public Health Crises and the Human Subjects of Biomedical Research: A Focus on COVID-19. Sher T; Wright RS Mayo Clin Proc; 2020 Jun; 95(6):1130-1131. PubMed ID: 32376104 [No Abstract] [Full Text] [Related]
16. Covid-19: Should doctors recommend treatments and vaccines when full data are not publicly available? Johnson RM; Doshi P; Healy D BMJ; 2020 Aug; 370():m3260. PubMed ID: 32839164 [No Abstract] [Full Text] [Related]
18. Audio Interview: Caring for Patients with Covid-19. Rubin EJ; Baden LR; Morrissey S N Engl J Med; 2020 Apr; 382(16):e50. PubMed ID: 32294372 [No Abstract] [Full Text] [Related]
19. COVID-19: How has the scientific community risen to the challenge? Straiton J Biotechniques; 2020 May; 68(5):232-234. PubMed ID: 32319301 [TBL] [Abstract][Full Text] [Related]
20. Clinical Trial End Points in Severe COVID-19. Desai A; Kulkarni A; Rajkumar SV; Gyawali B Mayo Clin Proc; 2020 Aug; 95(8):1578-1580. PubMed ID: 32753131 [No Abstract] [Full Text] [Related] [Next] [New Search]